Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-030045
Filing Date
2019-05-15
Accepted
2019-05-15 16:44:40
Documents
1
Period of Report
2019-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3913
  Complete submission text file 0001209191-19-030045.txt   5524
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O TRIMERIS, INC. 2530 MERIDIAN PARKWAY, 2ND FLOOR DURHAM NC 27713
Business Address
MATTINGLY MARTIN A (Reporting) CIK: 0001265782 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 19829092